The British Journal of Psychiatry (2009) 194: 360-364. doi: 10.1192/bjp.bp.108.049395
© 2009 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dean, C. E.
Right arrow Articles by Thuras, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dean, C. E.
Right arrow Articles by Thuras, P. D.

Mortality and tardive dyskinesia: long-term study using the US National Death Index

Charles E. Dean, MD and Paul D. Thuras, PhD

Mental Health Service Line, Minneapolis Veterans Administration Hospital, Minneapolis, Minnesota, USA

Correspondence: Charles E. Dean, Mental Health Service Line, 116A, One Veterans Drive, Minneapolis, MN 55417, USA. Email: charles.dean{at}med.va.gov

Declaration of interest

None.

Background

Whether the development of tardive dyskinesia leads to an increase in mortality is still unclear.

Aims

To explore the relationship between tardive dyskinesia and mortality over a 10-year period, using the National Death Index.

Method

Death certificates were obtained from the National Death Index on 1621 people repeatedly assessed for tardive dyskinesia by trained raters. Variables with the potential for influencing survival time were also investigated.

Results

Tardive dyskinesia was significantly associated with an increase in mortality (P<0.001), but this association became non-significant when drug course and age were entered in the regression analysis. Those who had taken only conventional antipsychotics were twice as likely to die compared with those taking atypical agents (P<0.02). For those aged 53–65 years, conventional agents were associated with a sevenfold increase in mortality.

Conclusions

Older individuals with tardive dyskinesia treated with conventional antipsychotics appear to have a shortened survival time.


Related articles in BJP:

Highlights of this issue
Kimberlie Dean
BJP 2009 194: A15. [Full Text]